This site use cookies
This site uses cookies that help us to improve our site by providing analytics and usage information. By clicking accept or continuing to use this site you are agreeing to our cookie policy. If you do not agree, please close this notice. Learn more

Exonate finalists for OBN’s 2020 Most Impactful UK Deal Award

Posted on 19 Oct 2020

Exonate finalists for OBN’s 2020 Most Impactful UK Deal Award.

Cambridge, UK; October, 2020- Exonate have been shortlisted into the final round for the Most Impactful UK Deal category of the 2020 OBN Awards. This is the 12th year of the OBN Awards which celebrate outstanding achievements throughout the life sciences industry. The winner will be selected by a judging panel of industry leaders and announced at the award ceremony in London. Due to new COVID guidelines this event will now be happening on Thursday 25th February 2021.

Dr Catherine Beech, Exonate CEO, commented: “We are delighted to be nominated and shortlisted for the Most Impactful Deal category of the OBN 2020 Awards. It is great to be recognised for our progress in transforming the lives of those suffering from retinal diseases.”



Exonate Limited

Sarah Buchallet, Marketing

Catherine Beech, CEO
Tel:  +44 (0) 1223 437042


Categories related to this article